Dartmouth Hitchcock researchers working on nasal vaccine for COVID | New Hampshire Public Radio
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward | TS Digest | The Scientist
BANITORE VIRALEZE BARRIER NASAL SPRAY | PNS eShop
Topical Microbial Therapeutics against Respiratory Viral Infections: Trends in Molecular Medicine
VIRALEZE Antiviral Nasal Spray 10ml - Viraleze
Researchers race to develop antiviral weapons to fight the pandemic coronavirus | Science | AAAS
First COVID-19 nasal spray vaccine being developed by Dartmouth Health, the NIH and Exothera | Healthcare Finance News
Glenmark and SaNOtize introduce nasal spray to treat Covid-19 in India
Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections - Spacova - 2023 - Microbial Biotechnology - Wiley Online Library
Home - Viraleze UK
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study - eClinicalMedicine
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients | Microbiology Spectrum
Antiviral Face Mask Functionalized with Solidified Hand Soap: Low-Cost Infection Prevention Clothing against Enveloped Viruses Such as SARS-CoV-2 | ACS Omega
Do we need nasal vaccines against COVID 19 to suppress the transmission of infections? - Brüssow - 2023 - Microbial Biotechnology - Wiley Online Library
SaNOtize's “revolutionary” Covid-19 nasal spray bolstered by Phase II trial
Nothing to sneeze at: nasal sprays to tackle Covid-19 - Pharmaceutical Technology
Nasaleze Travel Barrier Spray 800mg | Boots Ireland
How it Works - Viraleze
Home - Viraleze
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients | Microbiology Spectrum
A unique formula that creates a physical barrier proven to block COVID-19, colds and flu is on sale in November 2022 | Biosure UK | Self-Testing Solutions | Preventative Healthcare Experts | BioSure Global Leaders
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year's end
DHMC researchers to develop nasal spray COVID-19 vaccine
Nasal spray and throat spray from ActiMaris - ActiMaris
Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022? — JOGH
